ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,659.60
      -2.28%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.075
      -0.04%
      Bitcoin
      57,094.91
      -0.44%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Krystal Biotech Inc (KRYS)

      7. Krystal Biotech Inc (KRYS) News

      KRYS

      Krystal Biotech (KRYS)

      Krystal Biotech Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:KRYS
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      06/08/20234:39PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:KRYSKrystal Biotech Inc
      06/05/20237:00AMGlobeNewswire Inc.Krystal Biotech to Present at Upcoming Investor ConferencesNASDAQ:KRYSKrystal Biotech Inc
      06/02/20236:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KRYSKrystal Biotech Inc
      06/02/20236:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KRYSKrystal Biotech Inc
      05/31/20234:31PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:KRYSKrystal Biotech Inc
      05/23/20234:05PMGlobeNewswire Inc.Option Care Health Selected by Krystal Biotech as Part of a Limited Distribution Specialty Pharmacy Network for VYJUVEK™NASDAQ:KRYSKrystal Biotech Inc
      05/22/20234:36PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:KRYSKrystal Biotech Inc
      05/22/20237:33AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KRYSKrystal Biotech Inc
      05/22/20237:00AMGlobeNewswire Inc.Krystal Biotech Announces $160 Million Private Placement Equity FinancingNASDAQ:KRYSKrystal Biotech Inc
      05/19/20234:28PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:KRYSKrystal Biotech Inc
      05/19/20234:19PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:KRYSKrystal Biotech Inc
      05/19/20231:57PMGlobeNewswire Inc.Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene geperpavec-svdt) for the Treatment of Dystrophic Epidermolysis BullosaNASDAQ:KRYSKrystal Biotech Inc
      05/11/20234:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KRYSKrystal Biotech Inc
      05/11/20237:34AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KRYSKrystal Biotech Inc
      05/10/20239:46AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KRYSKrystal Biotech Inc
      05/08/20238:52AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KRYSKrystal Biotech Inc
      05/08/20238:49AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:KRYSKrystal Biotech Inc
      05/08/20238:28AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KRYSKrystal Biotech Inc
      05/08/20238:26AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KRYSKrystal Biotech Inc
      05/08/20238:23AMGlobeNewswire Inc.Krystal Biotech Announces First Quarter 2023 Financial Results and Operational HighlightsNASDAQ:KRYSKrystal Biotech Inc
      04/24/20237:05AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KRYSKrystal Biotech Inc
      04/24/20237:00AMGlobeNewswire Inc.Krystal Biotech Announces Clinical Data on Topical Application of B-VEC to the Eye to Treat Ocular Complications in a Patient with Dystrophic Epidermolysis Bullosa Under a Compassionate Use ProgramNASDAQ:KRYSKrystal Biotech Inc
      04/19/20234:20PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:KRYSKrystal Biotech Inc
      04/18/20237:00AMGlobeNewswire Inc.Jeune Aesthetics Announces Dosing of First Subject in Phase 1, Cohort 3 Study of KB301 for the Improvement of Lateral Canthal Lines at RestNASDAQ:KRYSKrystal Biotech Inc
      04/17/20234:51PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:KRYSKrystal Biotech Inc
      04/17/20234:51PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:KRYSKrystal Biotech Inc
      04/13/20237:00AMGlobeNewswire Inc.Krystal Biotech to Present at Association for Research in Vision and Ophthalmology Annual MeetingNASDAQ:KRYSKrystal Biotech Inc
      04/06/20234:44PMEdgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:KRYSKrystal Biotech Inc
      04/04/20234:23PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:KRYSKrystal Biotech Inc
       Showing the most relevant articles for your search:NASDAQ:KRYS

      Your Recent History

      NYSE
      ARIS
      Aris Water Solutions
      Delayed Upgrade Clock